Lucem Health

🚨 Last-minute addition to our panel!

We are delighted to announce that Melissa Putman, MD, Adult and Pediatric Endocrinologist at Massachusetts General Hospital, Associate Professor of Medicine at Harvard Medical School, and Director of the MGH Diabetes Research Center, is joining our panel for tomorrow's webinar.

Dr. Putman will bring her extensive clinical and research expertise in diabetes technologies and at-risk patient populations to our discussion on the future of Type 1 diabetes screening. Register today to join the conversation live!

TOMORROW, June 17 | 12 PM ET

Register here: https://hubs.ly/Q04lFKXf0

We're excited to welcome Kristy Drollinger to Lucem Health as our new Chief Product Officer!

Kristy brings deep expertise in healthcare product management and analytics across the payer, provider, direct-to-consumer, and health IT vendor segments. Her career spans early-stage startups that exited via acquisition, multi-hospital integrated delivery, and Fortune 5 enterprise. Most recently, she led product management and client services for the Clinical Surveillance & Compliance business at Wolters Kluwer Health.

As Chief Product Officer, Kristy's product leadership will be instrumental in advancing our mission and delivering greater value to providers and the communities they serve.

Welcome to the team, Kristy!

We’re headed to !

Holly Taylor, GM of Strategic Partnerships at Lucem Health, will be in New Orleans sharing how AI-enabled early detection can prevent avoidable DKA crises, and how proactive screening is key to preserving vital beta-cell function.

Because when it comes to type 1 , the first sign of disease should not be a life-threatening emergency.

Attending ? Connect with Holly in the 2026 Mobile App to continue the conversation.

Lucem Health is heading to New Orleans for 2026!

As the industry continues to advance new therapies, screening approaches, and standards of care, one question remains: how do we identify more people with before they experience a preventable crisis?

The Lucem Health team will be onsite discussing proactive screening, earlier intervention, patient engagement, and the role of -enabled precision health programs in helping health systems find and support at-risk patients sooner.

Attending ADA 2026? We'd love to connect. Reach out to Holly Taylor or Susan (Waters) Reagan to schedule time with our team.

Making proactive healthcare a clinical reality requires continuous collaboration, which is why Lucem Health is proud to sponsor the Healthcare Providers Transformation Assembly, hosted by The Millennium Alliance, in Miami on June 2-3.

We'd love to see you there. Our executive team, including Conrad Gudmundson, Chief Commercial Officer, and Susan (Waters) Reagan, VP of Health System Sales, will be on-site to unpack real-world strategies for programmatic proactive care and early disease detection.

We’re delighted to feature Michael J. Haller, MD, Professor and Chief of Pediatric Endocrinology at the University of Florida, in Lucem Health’s upcoming webinar on the future of Type 1 diabetes screening.

Dr. Haller will share clinical perspectives on:
- Preserving beta cell function
- Why current proactive screening guidelines are hard to operationalize and scale
- The potential for predictive AI to help pinpoint T1D risk outside of those standard protocols
- How earlier identification can reduce at diagnosis and improve long-term outcomes

📅 June 17 | 12 PM ET | Register here: https://hubs.ly/Q04hSXnN0

We’re delighted to feature Monica E. Bianco, MD, attending physician in endocrinology at & Robert H. Lurie Children's Hospital of Chicago and an Assistant Professor of Pediatrics at University Feinberg School of Medicine, in Lucem Health’s upcoming discussion on the future of Type 1 diabetes screening.

The conversation will explore how earlier identification, provider awareness, and predictive AI can pinpoint risk where current guidelines are hard to operationalize, helping to reduce preventable crises by improving long-term patient outcomes.

📅 June 17 | 12 PM ET | Register: https://hubs.ly/Q04h8csD0

What if the first sign of Type 1 diabetes wasn’t a life-threatening emergency?

We have guidelines for proactive screening—but operationalizing and scaling them is a major challenge. Healthcare needs a way to identify risk that standard protocols might miss.

Join Monica Bianco, MD, and Michael Haller, MD, and Holly Taylor to learn how predictive can pinpoint T1D risk beyond current guidelines and help prevent before it happens. Register now: https://hubs.ly/Q04gDT-P0

🗓️ June 17 | 12 PM ET

Most T1D cases are still first caught during a DKA crisis — a preventable emergency with real risk of death and ICU admission.

The clinical case for earlier identification isn't just compelling. It's actionable.

Join Lucem Health on Wednesday, June 17 from 12–1 PM ET for "Guidelines Aren't Enough: Rethinking How We Find Type 1 Diabetes Before DKA."

In this expert-led webinar, you'll walk away with:

* Proactive screening strategies you can apply in your practice
* Tools to address diagnostic inequities affecting at-risk populations
* A framework for beta cell preservation and earlier intervention
* How emerging diagnostics and predictive AI are closing the identification-to-intervention gap

This isn't just a conversation about challenging the status quo — it's a roadmap for what to do differently.

Register here: https://hubs.ly/Q04g5p8R0

Lucem Health's Chief Commercial Officer, Conrad Gudmundson, is a featured speaker at this year's NYC Health Innovation Week (May 5-9), hosted by HITLAB.

He will be presenting "From Precision Treatment to Precision Identification" on Tuesday, May 5th, at 2:50 PM as part of the Clinical Innovation & Emerging Therapies track, which is focused on building the future of digital health and AI through evidence-based innovation.

Want to see who else is speaking? Check out the full agenda and discover the key topics at the center of this year's event: https://hubs.ly/Q04dVKKz0